SURVYR

NUWE

Nuwellis, Inc.
$0.32
−$0.17 (34.69%)Oct 23 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-100%-66%-33%0%+33%Oct 2025Oct 2026Apr 202652w low $0.32
NUWESPY
Wall St. Highest PT $186.07 (+58046.9%) Wall St. Avg PT $152.52 (+47562.5%)
$0$64$128$191$255POC $6Hi $186Avg $153
Underwater Drawdown %Max DD -99.8%Current -99.8%
0.0%-99.8%
Relative Strength vs SPY-114.7% vs SPYUnderperforming
+135%0%-135%
1W
−$0.23 (41.82%)
1M
−$0.53 (62.35%)
3M
−$1.73 (84.39%)
6M
−$40.98 (99.23%)
YTD
−$60.58 (99.47%)
1Y
−$105.73 (99.70%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street & Morningstar coverage
Wall Street consensusNo covering analysts on file for NUWE
Analyst price targetsNo target range on file
Morningstar star ratingNot rated
Checked Wall Street & Morningstar feeds · All analyst rating changes ›
Recent analyst rating changes · 3
Reiterated
2024-08-13 · Roth MKM reiterated Buy on NUWE
Initiated
2024-07-29 · Roth MKM started covering NUWE at Buy
Downgrade
2023-11-08 · Ladenburg Thalmann downgraded NUWE from Buy to Neutral
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$1.2M
P/E (last 12 months)0.0
P/E (next 12 months, estimated)-0.1
52-week range$0.32 – $172.90
Revenue growth (latest quarter vs a year ago)+14.1%
Dividend yieldNo dividend

What they do

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie.

Healthcare · Medical Devices
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for NUWE yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

NUWE earningsNext report in 14 days
Next report
Wed Nov 11, 2026Before the open
EPS consensus-$13.65
Revenue consensus$0
Last 4 quarters · EPS vs estimate
May 12, 2026-$73.15est -$35.00−109.0%Below estimates
Mar 10, 2026-$52.50est -$54.60+3.9%Above estimates
Nov 12, 2025$19.60est -$602.70+103.2%Above estimates
Aug 14, 2025-$2134.65est -$661.50−222.7%Below estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-23 23:44:59 ET
24-0824-1125-0325-0525-0825-1126-0326-05-27709.562557.81
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$2.0M+14.1%
2026-03-31$2.4M–
2025-12-31$2.4M–
2025-09-30$2.2M–
2025-06-30$1.7M–

News & catalysts

More news
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System
GlobeNewswire · Oct 08
Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences
GlobeNewswire · Oct 01
Nuwellis Reports 31 Aquadex Console Sales in 2026, Expanding Recurring Revenue Opportunity
InvestorsHub · Sep 17
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
GlobeNewswire · Sep 17
Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs
GlobeNewswire · Sep 16
Rating changes
Reiterated
2024-08-13 · Roth MKM reiterated Buy on NUWE
Initiated
2024-07-29 · Roth MKM started covering NUWE at Buy
Downgrade
2023-11-08 · Ladenburg Thalmann downgraded NUWE from Buy to Neutral

Third-party analyst actions, not SURVYR.'s views. All rating changes

Stats refreshed 2026-10-23 23:44:59 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026